Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 75.00
0.00 (0.00%)
Aug 6, 2026, 2:13 PM JST
Ribomic Market Cap
Ribomic has a market cap or net worth of 4.24 billion as of August 5, 2026. Its market cap has decreased by -6.75% in one year.
Market Cap
4.24B
Enterprise Value
1.41B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
75.00
ChartMarket Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 4.24B, a decrease of -81.54%. That is a compound annual growth rate of -13.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 4.24B | 2.96% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noile-Immune Biotech | 5.99B |
| PRISM BioLab Co.,LTD | 5.77B |
| Soiken Holdings | 5.60B |
| Chiome Bioscience | 5.45B |
| Cyfuse Biomedical K.K. | 5.16B |
| Kohjin Bio | 4.63B |
| D. Western Therapeutics Institute | 4.54B |
| TMS Co., Ltd. | 4.51B |